Regina Woodson
Nurse Practitioner · Toledo, OHNPI 1730436395
Payments from drug & device makers
Across 343 payments — averaging $20.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$1K
- Supernus Pharmaceuticals, Inc.$977
- AbbVie$927
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$570
- Alkermes, Inc.$450
- Lundbeck LLC$438
- plus $2K from 17 others
What the payments were for
- Food & beverage$6,74398%
- Education$1182%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 57 | $1,202 |
| Supernus Pharmaceuticals, Inc. | 37 | $977 |
| AbbVie | 65 | $927 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 24 | $570 |
| Alkermes, Inc. | 23 | $450 |
| Lundbeck LLC | 22 | $438 |
| Johnson & Johnson | 13 | $406 |
| Ironshore Pharmaceuticals Inc. | 25 | $392 |
| Teva Pharmaceuticals USA, Inc. | 13 | $332 |
| Corium, LLC | 11 | $229 |
| Noven Therapeutics, LLC | 14 | $215 |
| Axsome Therapeutics, Inc. | 5 | $124 |
| Tris Pharma Inc | 7 | $112 |
| Indivior Inc. | 6 | $98 |
| Neurocrine Biosciences, Inc. | 4 | $84 |
| Vanda Pharmaceuticals Inc. | 3 | $80 |
| Collegium Pharmaceutical, Inc. | 4 | $65 |
| Sunovion Pharmaceuticals Inc. | 4 | $63 |
| Luye Pharma (USA) Ltd. | 2 | $30 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $25 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
| Vertical Pharmaceuticals, LLC | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QELBREE$486
- ABILIFY ASIMTUFII$125
- ABILIFY MAINTENA$125
- INVEGA SUSTENNA$125
- REXULTI$118
How this compares
$6,861 in reported general payments places this provider in the 95th percentile of 4,700 nurse practitioner providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RexultiBrexpiprazole | 25 | $40,336 |
| FetzimaLevomilnacipran Hcl | 13 | $6,566 |
| Methylphenidate ErMethylphenidate Hcl | 13 | $3,886 |
| Quetiapine Fumarate | 63 | $1,347 |
| Guanfacine Hcl ErGuanfacine Hcl | 22 | $1,079 |
| Atomoxetine Hcl | 12 | $808 |
| Oxcarbazepine | 16 | $519 |
| Prazosin Hcl | 26 | $503 |
| Amitriptyline Hcl | 15 | $341 |
| Mirtazapine | 12 | $274 |
| Buspirone Hcl | 30 | $253 |
| Risperidone | 38 | $233 |
| Methylphenidate Hcl | 14 | $214 |
| Lithium Carbonate ErLithium Carbonate | 11 | $202 |
| Alprazolam | 11 | $173 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Rexulti | $1,202 | $40,33625 claims |
| AbbVieFetzima | $927 | $6,56613 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,700 nurse practitioner providers in Ohio.
Other nurse practitioner in Toledo
- Vaughn HobletToledo$19K
- Margaret BobonichCleveland$235K
- Mary GallagherWestlake$229K
- Sonia HissettCincinnati$179K
- Ashley TaylorNew Albany$107K
- Beth FaimanCleveland$101K
- Katherine AlexanderColumbus$99K
- Tiffany JonesCincinnati$99K
- Kate NewmanWestlake$78K
- Daniella GerySouth Euclid$73K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.